Dopamine D2 receptor antagonist

0 marketed 2 in Phase 3 1 in Phase 2

This page covers all Dopamine D2 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dopamine D2 receptor, D2 receptor.

Targets

Dopamine D2 receptor · D2 receptor

Phase 3 pipeline (2)

Supemtek® · Assistance Publique - Hôpitaux de Paris · Psychiatry
Supemtek is a small molecule drug that targets the dopamine D2 receptor.
OPC-12759 · Otsuka Pharmaceutical Co., Ltd. · Psychiatry
OPC-12759 is a selective dopamine D2 receptor antagonist.

Phase 2 pipeline (1)

ACT-539313 · Idorsia Pharmaceuticals Ltd. · Psychiatry
ACT-539313 is a selective dopamine D2 receptor antagonist.